The type I interferon (IFN) system is persistently activated in systemic lupus erythematosus (SLE) and many other systemic autoimmune diseases. Studies have shown an association between SLE and several gene variants within the type I IFN system. We investigated whether single-nucleotide polymorphisms (SNPs) associated with SLE and other autoimmune diseases affect the IFN-α production in healthy individuals. Plasmacytoid dendritic cells ( pDCs), B cells and NK cells were isolated from peripheral blood of healthy individuals and stimulated with RNA-containing immune complexes (ICs), herpes simplex virus (HSV) or the oligonucleotide ODN2216. IFN-α production by pDCs alone or in cocultures with B or NK cells was measured by an immunoassay. All donors were genotyped with the 200K ImmunoChip, and a 5 bp CGGGG length polymorphism in the IFN regulatory factor 5 gene (IRF5) was genotyped by PCR. We found associations between IFN-α production and 18-86 SNPs (P ≤ 0.001), depending on the combination of the stimulated cell types. However, only three of these associated SNPs were shared between the cell-type combinations. Several SNPs showed novel associations to the type I IFN system among all the associated SNPs, whereas some loci have been described earlier for their association with SLE. Furthermore, we found that the SLE-risk variant of the IRF5 CGGGG-indel was associated with lower IFN-α production. We conclude that the genetic variants affecting the IFN-α production highlight the intricate regulation of the type I IFN system and the importance of understanding the mechanisms behind the dysregulated type I IFN system in SLE.
Introduction
Type I interferon (IFN) is important for the immune response against viruses, but can also contribute to inflammation and loss of tolerance when the production of IFN is dysregulated. A persistent activation of the type I IFN system occurs in several autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE) and Sjögren's syndrome. Many of these patients have elevated serum levels of IFN-α and an overexpression of type I IFN-inducible genes (IFN signature) as reviewed in Refs. (1, 2) . Recently, more than 50 SLE-associated genetic variants have been identified, and over half of them are linked to the type I IFN system (3, 4) . Taken together, these findings corroborate a strong etiopathogenic role of the type I IFN system in SLE.
The main producers of IFN-α are the plasmacytoid dendritic cells (pDCs). They constitute only 0.2-0.8% of the peripheral blood mononuclear cells (PBMCs), but produce large amounts of IFN-α per cell basis in response to viruses, e.g. HSV (5, 6) . Another potent and thoroughly studied IFN-α inducer of pDCs is the synthetic oligodeoxynucleotide ODN2216 that mimics bacterial hypomethylated CpG DNA (7) . Both HSV and CpG activation of pDCs involve engagement of Toll-like receptors (TLRs), especially TLR9. In many autoimmune diseases with an activated type I IFN system, e.g. SLE, the pDCs are stimulated by immune complexes (ICs) consisting of RNA-or DNA-containing proteins and autoantibodies (1, 8) . The pDCs interact with other immune cells, and we have previously shown that the IFN-α production by pDCs stimulated with RNAcontaining IC (RNA-IC) was strongly enhanced by natural killer (NK) cells and B cells (9) (10) (11) . To be able to trigger IFN-α production, the ICs are internalized into pDCs via Fcγ receptor IIa (FcγRIIa) and bind to the endosomal TLR7 or TLR9 (12) (13) (14) . This leads to activation of a signaling pathway involving the MyD88 adaptor protein and subsequent phosphorylation of IFN regulatory factors (IRF) 7 and IRF5, both of which are highly expressed in pDCs and are crucial for the type I IFN induction (5) . We have previously found a strong association with SLE for IRF5 and two genes connected to the type I IFN response, namely tyrosine kinase 2 (TYK2) and signal transducer and activator of transcription (STAT) 4 (15) (16) (17) . Later, several other genes within the type I IFN system have been associated with increased risk for SLE (18) (19) (20) . Although many genetic associations with the type I IFN have been demonstrated in SLE, only a few functional effects on either the type I IFN production or signaling have been reported. In this study, we therefore asked whether the IFN-α production by pDCs stimulated with TLR agonists, and, in particular, RNA-containing IC, is affected by genetic risk variants associated with SLE and other autoimmune diseases.
Results

IFN-α-producing capacity by healthy individuals shows a large variation
We initially investigated the IFN-α production by pDCs, alone or in cocultures with B or NK cells, from a large number of healthy individuals (n = 168). The cultures stimulated with RNA-IC, HSV or ODN2216 showed a large variation in the IFN-α levels regardless of the cell-type combination or the IFN-inducer, from almost no IFN-α produced to >100 000 U/ml (Fig. 1A) . The highest IFN-α production was obtained when the pDCs were cocultivated with NK cells and stimulated with RNA-IC (Fig. 1A) . To capture the variation of the IFN-α levels across the cell-type combinations and stimulators, we performed a principal component analysis (PCA). The first three principal components together accounted for 85% of the variation of the IFN-α production. The HSV-and ODN2216-stimulated cells were closely clustered within the stimulator, whereas the RNA-IC-stimulated cells showed a more broad distribution (Fig. 1B) . No significant differences were detected in the IFN-α-producing capacity between males and females (P > 0.1, not shown), and there was no correlation between age and the IFN-α production by pDCs (not shown).
Gene variants associated with IFN-α production
Next we analyzed whether the genetic variants previously reported to be associated with autoimmune diseases, and included in the ImmunoChip, could be important for the variable IFN-α production. In total, 364 single-nucleotide polymorphisms (SNPs), of which 168 SNPs were independent, representing 175 loci, were associated with the IFN-α production (P < 0.001) (Supplementary Material, Tables S1-S3) Tables S1-S3) . Thus, a large number of SNPs can contribute to the observed interindividual variation in the IFN-α production.
The associated loci shared by different cell-type combinations or IFN-inducers
The IFN-inducers used in this study utilize both common and separate pathways to induce type I IFN production. It was therefore of interest to study whether the same SNPs were associated with the IFN-α production for different cell-type combinations and IFN-inducers. Only two loci associated with IFN-α production were shared between the three cell-type combinations ( Fig. 2A) , whereas one additional locus was found to be shared between all the investigated IFN-inducers (Fig. 2B) .
The shared associated loci and the genotype of the corresponding SNPs were plotted against the IFN-α levels. The three shared loci included SNPs located in, or close to, the gene regions encoding the long intergenic non-coding (linc) RNA RP5-1043L13.1 (rs735237, Fig. 3A) , interleukin (IL)-2 receptor β (IL2RB, rs9607418, Fig. 3B ) and in a region containing pseudogenes on chromosome 5 (5:85468473, rs1035382, Fig. 3C ). The linc RNA SNP rs735237 was shared by all inducers, whereas the IL2RB rs9607418 and the SNP rs1035382 were shared by all cell-type combinations stimulated with HSV. Individuals homozygous for the minor A allele of linc RNA SNP rs735237 (Fig. 3A) produced less IFN-α than those with other genotypes (G/G: 5671, A/G: 4348, A/A: 1324, IFN-α, median U/ml). There was a similar trend for the IL2RB rs9607418 (Fig. 3B ), but the effect was seen already with one minor allele. For the SNP rs1035382 (Fig. 3C) , no individuals were homozygous for the minor allele, however, having one minor G allele conferred to higher IFN-α production (A/A: 4737 versus G/A: 11 724, IFN-α, median U/ml). The three shared loci may have a general importance for the IFN-α production by the pDC or could reflect the different activation pathways used by the IFNinducers and cell-type combinations.
SNPs in SLE-related genes associated with IFN-α production by pDCs
Further analysis showed that several of the SNPs associated with the IFN-α production by pDCs were located in genes previously shown to confer increased risk for SLE or specific clinical manifestations in SLE (Fig. 4) . When using RNA-IC as IFN-inducer, these included; IL10 (21), RAS guanyl releasing protein 3 (calcium-and DAG-regulated) (RASGRP3) (22) and v-ets avian erythroblastosis virus E26 oncogene homolog 1 (ETS1) (23) (Fig. 4A-C) . Rs1800890 in IL10 (Fig. 4A ) is in relatively high linkage equilibrium (LD; r 2 = 0.67) with the SLE-associated minor allele of SNP rs1800896 (24) , and the minor A allele of rs1800890 was associated with a lower IFN-α level (T/T: 16 192, A/T: 21 150, A/A: 4421, IFN-α, median U/ml). Several of the associated SNPs in our study were located in known SLE-associated genes, but were not in linkage disequilibrium with earlier SLE-risk SNPs in these genes. The minor alleles of both rs9679399 (RASGRP3, Fig. 4B ) and rs7928186 (ETS1, Fig. 4C ) were associated with higher IFN-α production. The ODN2216-induced IFN-α production was associated with SNPs in the phox (PX) domain containing serine/threonine kinase (PXK) (25) and TNF receptor-associated factor 3 interacting protein 2 (TRAF3IP2) loci (26) (Fig. 4D-F) . Notably, the PXK rs74477836 in our study is in relatively high LD (r 2 = 0.70) with the SLE-associated PXK rs6445975 (25) . The minor G allele of the latter SNP was associated with increased risk for SLE and the minor G allele of the PXK rs74477836 was significantly associated with higher IFN-α production (A/A: 3660, G/A: 6387, G/G: 18 519, IFN-α, median U/ml) (Fig. 4D) . We further observed associations for three SNPs in low LD, located in and around the TRAF3IP2 gene. The minor alleles of the TRAF3IP2 rs1883136 and rs7769061 ( Fig. 4E and not shown, respectively) were associated with lower ODN2216-stimulated IFN-α production, whereas the minor allele of rs12205868 ( Fig. 4F ) was associated with higher IFN-α levels. rs12205868 is also in relatively high LD (r 2 = 0.7) with two eQTL SNPs in the TRAF3IP2 gene (rs10457242 and rs1573741, Supplementary Material, Table S4 ). Thus, minor alleles, often referred as risk variants of specific SNPs, can be associated either with increased or decreased IFN-α production.
Gene variants with novel associations to the type I IFN system
Among the most associated SNPs, in the present study, we also found possible associations to genes with no previously reported role in SLE or type I IFN production. A panel selected from the most significant SNPs is described below (Table 1) . For the RNA-IC-induced IFN-α production, we found associations with SNPs rs58962228 located in the gene G protein receptor 12 (GPR12), rs4325270 in the RNA binding protein, bicaudal C homolog 1 (BICC1) and rs7597373 in the gene solute carrier family 8 (sodium/calcium exchanger) member 1 (SLC8A1) ( Table 1) . Furthermore, when stimulating cells with HSV, the SNPs rs6757588 located in Rho GTPase Activating Protein 15 (ARHGAP15), rs2263297 in HLA-E and rs3788718 in cadherin, EGF LAG sevenpass G-type receptor 1 (CELSR1) were associated with IFN-α production ( Table 1) . For ODN2216-stimulated cells, the SNPs associated with IFN-α production were rs16905117 located near the zinc finger and AT hook domain containing gene (ZFAT1), rs6460033 in tRNA-yW synthesizing protein 1 homolog B (TYW1B) and rs7747909 in IL17A (Table 1 ). Here we show that SNPs in loci with highly variable functions might contribute to the regulation of the IFN-α production by pDCs.
IRF5 gene variants affect the IFN-α production
We previously demonstrated a strong association between susceptibility to SLE and several SNPs as well as a 5 bp long IRF5 insertion-deletion polymorphism (CGGGG-indel) in or near the IRF5 gene (15, 17) . A haplotype of four SNPs in IRF5 was also associated with elevated serum IFN-α activity in SLE patients (27) . Therefore, we investigated whether the 5 bp CGGGG-indel and the previously published IRF5 haplotype could affect the IFN-α production by stimulated pDCs. Surprisingly, when stimulating cocultures of pDCs and B cells, individuals with the longer variant of the IRF5 CGGGG-indel, previously defined as the risk variant, produced less IFN-α (P < 0.05) compared with individuals homozygous for the shorter variant of the IRF5 CGGGG-indel ( Fig. 5A and B) , whereas no such effect was detected for pDCs alone or in cocultures with NK cells (not shown). The IRF5 haplotypes are categorized as risk (R), neutral (N) or protective (P) according to their association with SLE. The IRF5 haplotypes were defined by the SNPs: rs3757385, rs3807306, rs10488631 and rs2280714: CAGA (R), CAAA (N), CCAA (N), ACAA (P) and ACAG (P). The original rs2004640 (27) was replaced by rs3757385 (r 2 = 0.84), because rs2004640 is not included on the ImmunoChip. We found, when stimulating pDCs together with B cells, that individuals homozygous for the protective haplotype (P/P) ( pDCs with B cells/ODN2216), (E) TRAF3IP2 rs1883136 ( pDCs/ODN2216) and (F) TRAF3IP2 rs12205868 ( pDCs with NK cells/ODN2216). IFN-α levels (U/ml) in cell cultures were measured after 20 h by an immunoassay. Statistical analyses were performed by using the Mann-Whitney signed rank test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Each data point represents one individual donor, and the horizontal lines show the median values.
produced higher levels of IFN-α compared with those with neutral or risk haplotypes ( Fig. 5C and D) . This difference was significant for P/P versus P/N, and P/P versus R/R (P < 0.05), and P/P versus N/N (P < 0.01) when stimulating with RNA-IC (Fig. 5C ),
and for P/P versus P/N (P < 0.05) and for P/P versus N/N (P < 0.01) when stimulating with ODN2216 (Fig. 5D) . Recently, an additional SLE risk variant, the SNP rs4728142 located in the promoter region of IRF5, was reported to be associated with increased The SNPs are selected from the most significant SNPs, and with no previously reported association with the type I IFN production. pDCs, B and NK cells from healthy individuals were stimulated with RNA-IC, HSV or ODN2216. IFN-α levels (U/ml) in cell cultures were measured after 20 h by an immunoassay. MAF, minor allele frequency. Statistical analysis was performed by using the Kruskal-Wallis test. expression of the IRF5 gene (28) . As for the IRF5 indel and haplotype, we found that individuals with the minor risk allele of rs4728142 produced lower levels of IFN-α compared with those homozygous for major allele (P < 0.05) when stimulating pDCs together with B cells (Supplementary Material, Fig. S1 ).
Cellular functions of the loci associated with IFN-α production
To identify the networks and pathways/cellular functions involved, we combined all the loci that were associated with IFN-α production for each IFN-inducer or cell-type combination and analyzed with Ingenuity Pathway Analysis (IPA) software. The network with the highest score, for pDCs, featured genes involved in the cell cycle, cell morphology and cellular function and maintenance (Fig. 6A) . In this network, ubiquitin C (UBC) was highlighted as a central molecule (Fig. 6A) . The top network for the genes associated with the IFN-α production in the cocultures of pDCs and B cells included genes involved in DNA replication, recombination and repair, gene expression and hereditary disorder. Also here the central molecule was the UBC (Fig. 6B) . For the cocultures of pDCs and NK cells, the suggested top network included genes involved in cellular development, cellular growth and proliferation, hematological system development and function and the central molecules were, e.g. IL17A, Akt and ERK1/2 (Fig. 6C) . The pathways/cellular functions obtaining the highest scores were similar for the different cell-type combinations, e.g. cell morphology and development. An exception was cell-to-cell signaling and interactions that only achieved high score when pDCs were cocultivated with NK or B cells. This further emphasizes the importance of cell-cell signaling for the enhanced IFN-α production in the cocultures. 
IFN-α-associated SNPs and their relevance for SLE
We evaluated whether the SNPs associated with the IFN-α production also were associated with SLE. To test this, we analyzed the nine SNPs from Table 1 , which contains SNPs selected from the most associated SNPs in our study. These SNPs were analyzed for their association with SLE in a European GWAS study (Bentham et al., personal communication). We found that the SNP rs3788718 (CELSR1, P = 0.003) was significantly associated with SLE and passed a Bonferroni correction at 0.05 significance level. By performing a permutation test (see Materials and Methods), we also found that these nine selected SNPs, as a set, were significantly associated with SLE (P = 0.024). The finding that the most significant SNPs in the present study also were associated with SLE strengthens the relevance of our study and the importance of the type I IFN system in SLE.
Finally, we performed gene set enrichment analysis of SLE-associated SNPs located in loci with or without an association with IFN-α levels in the present study. Among the significant pathways (FDR < 5%) for the SLE-SNPs located in IFN-α-associated loci, we found several interesting subnetworks, e.g. ubiquitinassociated and SH3 domain containing A (UBASH3A), the suppressor of cytokine signaling (SOCS) 5, Janus kinase (JAK) 1, TYK2, and granulocyte macrophage colony-stimulating factor (GM-CSF) signaling (Supplementary Material, Table S5 ).
Discussion
The observation that several risk genes associated with SLE are connected to the type I IFN signaling pathway suggests that autoimmune risk gene variants can determine the IFN response. In order to clarify a possible connection between the IFN production and autoimmune risk polymorphisms, we investigated the IFN-α-producing capacity by pDCs from healthy individuals genotyped by the ImmunoChip. We found a large interindividual variation in the IFN-α-producing capacity with associations between totally 364 SNPs, representing 175 loci, and the IFN-α production, indicating genetic regulation of the IFN-α response. The rather high number of associated SNPs could be due to the dense coverage of many loci on the ImmunoChip and that several of the associated SNPs were in high LD. This could also be explained by the fact that many SNPs on the ImmunoChip are selected from genetic studies on autoimmune diseases where several SNPs in risk genes have been identified. The limitation of the present study is the moderate number of the included individual cell donors, which results in relatively low statistical power. Three of the associated loci were shared between the IFN-inducers or cell-type combinations. The few shared loci reflects the different IFN-induction pathways and regulatory mechanisms involved in the pDC/NK and pDC/B cell cross-talk, especially for the RNA-IC-stimulated cells as indicated by the PCA plot (Fig. 1B) , and could indicate that the shared SNPs are generally important for the IFN-α production by pDCs.
Aberrant expression of cytokines and cytokine receptors is a common phenomenon in several autoimmune diseases (29) . In our study, one of the shared loci associated with IFN-α production was located in a region containing multiple genes involved in the production or action of cytokines, including the intronic SNP rs9607418 in the IL2RB gene. IL-2 and IL-15 share the IL-2Rβ chain for signaling, and IL-2 can modulate the activation and survival of pDCs, whereas IL-15 enhances the IFN-α production by HSV-stimulated pDCs (30, 31) . Furthermore, IFN-α promotes the expression of the high-affinity IL-15Rα chain and a number of IL-15-mediated effects, such as increased survival and cytotoxicity of NK and T cells (32) . It is known that SLE patients have impaired IL-2 production but increased levels of IL-15 and IFN-α. Therefore, the SNP rs9607418 genotype associated with the higher IFN-α production could theoretically augment the expression of functional IL-15R and functional effects of IL-15. We also found an association to the transcription factor ETS-1, which influences the expression of IL-2Rβ and IL-17 (33, 34) , both associated with IFN-α production in our study. Taken together, it is tempting to speculate that small functional alterations of cytokine genes and their receptors due to gene polymorphisms may have an impact on the susceptibility to develop autoimmune diseases with an IFN signature, e.g. SLE.
The two other shared loci were located in gene regions containing a linc RNA and pseudogenes. Increasing attention has been focused on the function of non-coding RNAs and their involvement in disease mechanisms (35) . Although the role of linc RNA for pDC function is still unknown, the genotype of the SNP rs735237 in linc RNA RP5.1043L13.1 clearly affected the RNA-IC-stimulated IFN-α production in cocultures of pDCs and B cells.
Among the known SLE susceptibility genes associated with the IFN-α production in our study, two of the SNPs, the PXK rs74477836 and rs1800890 upstream of IL10, were in high LD with the SLE-associated SNPs PXK rs6445975 and IL10 rs1800896, respectively (24, 25) . The PXK is involved in internalization of surface proteins into endosomes (36) , which is important for type I IFN induction by several stimuli. The minor alleles of the PXK rs74477836 and rs6445975 probably represent the same signal and could indicate a link between higher IFN-α production and an increased risk for SLE (25) . The cytokine IL-10 has an important role in the regulation of an immune response by suppressing activated immune cells and cytokine production, including IFN-α. On the other hand, IL-10 contributes to the hyperactivation of B cells resulting in autoantibody formation, and patients with SLE display elevated serum levels of IL-10 that correlate with disease activity (37, 38) . The regulatory functions and elevated levels of IL-10 in SLE are consistent with the effect of the IL10 rs1800890 minor allele that confers both lower IFN-α production and is linked to the SLE risk SNP rs1800896 (24) . Three independent association signals were found in and around the TRAF3IP2 gene, and one of these SNPs were also in high LD with eQTL-SNPs, indicating a direct effect of the transcription of the gene. The protein encoded by the TRAF3IP2 gene takes part in antiviral signaling and the production of IFN-β and several IFN-inducible proteins, which is relevant in context of autoimmune diseases, e.g. SLE (39) . We conclude that the SNPs found to be conferred as risk for SLE and that are in LD with the SNPs associated with IFN-α production in the present study could have different effects on the IFN-α levels in vivo, depending on the total genetic background, epigenetic modifications and environmental factors.
Several of the SNPs associated with IFN-α production were located in loci that, to our knowledge, are novel regarding their role in the type I IFN production (Table 1) . These loci are connected to diverse functions, e.g. the G-protein-coupled receptor, GPR12, which is involved in the regulation of cell proliferation and survival (40) . Furthermore, several associations were found with cell adhesion molecules, a finding in line with our previous observation that the stimulatory effect of B cells on the IFN-α production by pDCs was dependent on cell-cell contact (11) . For instance, the SNP rs4325270 in the promoter region of BICC1 (41), which could influence the transcription of the gene, was only associated with the IFN-α production by pDC and B cell cocultures stimulated with RNA-IC. The IFN-α production in the cocultures of pDCs and NK cells was associated with IL17A gene variants. The latter enhances the surface expression of the adhesion molecules ICAM-1 and VCAM-1, both important for the pDC and NK cell interactions (10, 42, 43) . In addition, association to CELSR1 further indicates the role of cellular cross-talk for the IFN-α production by pDCs (44) . The SNP rs2263297 upstream of HLA-E was associated with IFN-α production when pDCs were cocultivated with B cells and stimulated with HSV. The HLA-E expression is enhanced by several viruses as well as type I IFNs (45) and the HLA-E complex plays an important role in regulating antiviral immunity (46) . Therefore, it is intriguing that the genotype of rs2263297 upstream of HLA-E is associated with the virusinduced IFN-α production.
We earlier demonstrated that SLE patients have an increased expression of IRF5, which was associated with IRF5-SLE risk haplotypes (17, 47) . An IRF5-SLE-risk haplotype has also been associated with higher IFN-α serum activity in SLE patients (27) . To our surprise, we noted that both the SLE-protective variants of the IRF5 CGGGG-indel and the SLE-protective haplotype, consisting of four SNPs, were associated with higher IFN-α production. A similar pattern was also seen for the IRF5 SNP rs4728142, even though this SNP represents an additional association signal not represented by the IRF5 haplotype (28) . The reason for this finding in not clear, but could reflect the fact that the SLE patients express a specific IRF5 transcript repertoire distinct from healthy individuals (47) . Possible explanations could be that other gene polymorphisms, epigenetic changes or the cellular microenvironment in SLE patients may interact with the IRF5 expression and affect the final function of IRF5 in the IFN-α response.
Finally, we analyzed a selection of SNPs associated with IFN-α production for their association with SLE in a separate European GWAS study. We found that the selected SNPs were significantly associated with SLE as a set, which considering SLE as a type I IFN-driven disease strengthens the relevance of the present study, and might reveal molecules important for the regulation of the type I IFN system. In addition, the SLE-associated SNPs located in IFN-α-associated loci were enriched in pathways involved in cytokine signaling and several of them are connected to type I IFN signaling. Notably, we have shown earlier that both GM-CSF and IFN-α priming of pDCs increased the IFN-α production (9) . Furthermore, the SOCSs are negative regulators of the type I IFN signaling (48) , and JAK1 and TYK2 are key signaling molecules downstream of the IFNAR (49) .
We conclude that the SLE-risk gene variants can either give rise to decreased or increased IFN-α production by pDCs from healthy individuals, but the magnitude of the final cytokine level is defined by several combined factors in each individual. The large variation in the IFN-α production could reflect the delicate balance between an effective immune response versus an enhanced risk to develop autoimmune diseases. We suggest that, although many diseaseassociated gene variants are present at low allele frequencies in the healthy population, our approach to use relevant immune cells from genotyped healthy individuals can aid in understanding the mechanisms behind the activated type I IFN system in SLE and other autoimmune diseases.
Materials and Methods
Study population
The studied population consisted of 130 females and 38 males, at an age between 19 and 76 years (45 ± 14, mean ± SD). All individuals were included in the Uppsala Bioresource, which consists of 2000 healthy blood donors visiting the Department of Transfusion Medicine, Uppsala University Hospital, Sweden. The study was approved by the regional ethical review board in Uppsala, and written informed consent was obtained from all blood donors. The total number of donors for each cell combination and stimuli were pDC-RNA-IC (n = 168), pDC-HSV (n = 164), pDC-ODN (n = 162), pDC + B-RNA-IC (n = 163), pDC + B-HSV (n = 164), pDC + B-ODN (n = 158), pDC + NK-RNA-IC (n = 108), pDC + NK-HSV (n = 106) and pDC + NK-ODN (n = 103).
Cell isolation and culture conditions
PBMCs were purified from buffy coats using Ficoll-Hypaque (GE Healthcare, Uppsala, Sweden) density-gradient centrifugation. PDCs and NK cells were isolated from PBMCs by negative selection using a pDC Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) and an NK Cell Isolation Kit (Miltenyi Biotec), respectively. The B cells were isolated by positive selection using a CD19+ B Cell Isolation Kit (Miltenyi Biotec) according to the manufacturer's instructions. Viability and purity of the isolated cell populations were determined by flow cytometry (FACSCantoII, BD Biosciences, San Jose, CA) after staining with anti-BDCA2 (Miltenyi Biotec), anti-CD56 or anti-CD20 (BD Biosciences) mAbs. The purity of all cell preparations was at least 93%. Flow cytometric data were analyzed by Diva 6. 
IFN-inducers
U1 snRNP particles were purified from HeLa cells as described before (51). IgG was purified from an SLE patient serum containing autoantibodies to SmB, SmD, RNP-A, RNP-C, ribosomal P antigen, histone and dsDNA (SLE-Ig) by protein G chromatography. The U1 snRNP particles and SLE-Ig were used in cell cultures at final concentrations of 2.5 μg/ml and 1 mg/ml, respectively. Phosphorothioate-modified CpG A oligonucleotide ODN2216 (CyberGene, Huddinge, Sweden) (52) and UV-inactivated HSV type I were used at optimal concentration of 3 μg/ml and 10% (v/v), respectively (11).
Genotyping
Genomic DNA was obtained from whole blood samples using QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany). All blood donors (Uppsala Bioresource) were genotyped for 196 524 SNPs and indels included in the Illumina 200K Infinium ImmunoChip (Illumina Inc., San Diego, CA). The genotype data passed quality control, including genotype calling by cluster classification and the removal of population outliers and SNPs with >5% missing data. The individual call rate was more than 95%. The genotype frequencies of the SNPs within the cohort fulfilled the criteria of Hardy-Weinberg equilibrium (P > 1 × 10 −6 ). All individuals were unrelated ( pi hat < 0.2, estimated with identity by descent method) and of European ancestry, verified by PCA using the HapMap 3 sample collection.
IRF5 CGGGG-indel analysis
The 5 bp IRF5 CGGGG-indel (17) was amplified as a 100/105 bp PCR fragment, and the amplified fragments were separated on 4% MetaPhor high-resolution agarose gels (Cambrex Bio Science Rockland Inc., Rockland, ME) and visualized by ethidium bromide staining.
Statistics and pathway analysis
For each SNP, individuals were divided into three genotypes: heterozygous or homozygous for the major or minor alleles. The statistical significance of differences in the IFN-α levels were analyzed by using the Kruskal-Wallis test, whereas the differences between the groups were analyzed by the Mann-Whitney signed rank test (GraphPad Prism 6.0, San Diego, CA). The PCA was performed by IBM SPSS version 21.0 (SPSS, http://www.spss.com/). To be considered for further analysis, the change in the IFN-α levels between the three genotypes had to be consistent or additive. The SNPs that failed to fulfill this distribution criterion were excluded from the analysis. The eQTL analysis was performed on HapMap3 lymphoblastoid cell lines from individuals with European ancestry by using GENEVAR (GENe Expression VARiation) database (Version 3.3.0) (53) . To analyze whether the SNPs associated with IFN-α production were also associated with SLE, we performed a permutation test using a European GWAS data set for SLE. The GWAS data were extracted from a meta-analysis (Bentham et al., manuscript in preparation) based on studies of European and Chinese cohorts (22, 25, 54) . First, nine SNPs selected from the most associated SNPs in our study were analyzed for their association with SLE, both separately and as a set of SNPs, using Fisher's method for combining P-values. We used a permutation procedure (10 000 permutations) to estimate the null distribution of the chi-squared statistic from Fisher's test on nine randomly chosen SNPs from the European GWAS data. The estimated P-value for this test is the proportion of number of times a random chi-squared statistic for the permutations was higher than that for the selected nine SNPs. The biological functions and pathways for the associated loci were analyzed by IPA (Ingenuity Systems Inc., Redwood City, CA). To further validate our data, we performed an association analysis on a Swedish SLE cohort, consisting of 1155 SLE patients and 2946 controls extracted from a larger ImmunoChip genotyping study (Vyse et al., to be published). Next, we extracted the 3000 SNPs with highest and lowest P-values for SLE and analyzed their association to the IFN-α production in the present study. The QQ plots of the IFN-α association for the extracted SNPs (Supplementary Material, Fig. S2 ) showed that P-values were generally underestimated and that our study has relatively low power. However, with a cut-off P < 0.001, the SLE-associated SNPs had significantly lower IFN-α P-values compared with non-SLE SNPs (Mann-Whitney signed-rank test, P < 0.05). To investigate a possible gene set enrichment for SLE-and IFN-associated loci, we analyzed the SLE-associated SNPs (FDR < 5%) and among these SNPs extracted independent SNPs (using PLINK, parameters -clump-kb 500 and -clump-r2 0.05) located in loci with or without IFN-α association in the present study. Subsequently, the gene set enrichment was analyzed by using DEPICT (55) .
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